VIEMED HEALTHCARE, INC. Quarterly Operating Income (Loss) in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Viemed Healthcare, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q2 2024.
  • Viemed Healthcare, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $3.62M, a 24.6% increase year-over-year.
  • Viemed Healthcare, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $15.3M, a 55.7% increase year-over-year.
  • Viemed Healthcare, Inc. annual Operating Income (Loss) for 2023 was $14.3M, a 73.7% increase from 2022.
  • Viemed Healthcare, Inc. annual Operating Income (Loss) for 2022 was $8.25M, a 28.7% decline from 2021.
  • Viemed Healthcare, Inc. annual Operating Income (Loss) for 2021 was $11.6M, a 56.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $15.3M $3.62M +$715K +24.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $14.6M $2.2M +$270K +14% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $14.3M $5.29M +$1.76M +49.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $12.6M $4.21M +$2.74M +186% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $9.84M $2.9M +$1.9M +190% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $7.94M $1.93M -$314K -14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $8.25M $3.53M -$1.13M -24.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $9.38M $1.47M -$1.45M -49.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $10.8M $1M -$1.66M -62.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $12.5M $2.25M +$916K +68.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $11.6M $4.67M -$602K -11.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $12.2M $2.92M -$1.12M -27.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $13.3M $2.66M -$10.2M -79.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $23.5M $1.33M -$3.28M -71.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $26.8M $5.27M +$2.58M +95.7% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-03
Q3 2020 $24.2M $4.04M +$1.85M +84.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $22.4M $12.9M +$11.2M +673% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $11.2M $4.62M +$2.3M +99.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q4 2019 $8.86M $2.69M -$224K -7.68% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 $9.08M $2.19M -$325K -12.9% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-03
Q2 2019 $9.41M $1.66M -$624K -27.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-03
Q1 2019 $10M $2.32M -$26K -1.11% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-03
Q4 2018 $10.1M $2.92M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 $2.51M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-04
Q2 2018 $2.29M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-04
Q1 2018 $2.34M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.